MDIT OTC
Medite Cancer Diagnostics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$16M
-9.1% ▼
Total Liabilities
$10M
+6.6% ▲
Shareholders Equity
$6M
-27.8% ▼
Cash & Investments
$490K
+353.7% ▲
Total Debt
$5M
+31.9% ▲
Net Debt
$5M
+23.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| — Assets — | |||
| Cash | $587K | $108K | $490K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $587K | $108K | $490K |
| Net Receivables | $2M | $1M | $453K |
| Inventory | $3M | $4M | $2M |
| Other Current Assets | $0 | $0 | $417K |
| Total Current Assets | $6M | $5M | $3M |
| Property, Plant & Equip. | $2M | $2M | $2M |
| Goodwill & Intangibles | $15M | $15M | $15M |
| Long-Term Investments | $0 | -$25K | $0 |
| Other Non-Current Assets | -$4M | $151K | -$4M |
| Total Non-Current Assets | $13M | $12M | $12M |
| Total Assets | $18M | $18M | $16M |
| — Liabilities — | |||
| Accounts Payable | $652K | $1M | $1M |
| Short-Term Debt | $3M | $4M | $376K |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $139K | $1M | $987K |
| Total Current Liabilities | $6M | $7M | $4M |
| Long-Term Debt | $846K | $195K | $5M |
| Other Non-Current Liab. | $0 | $0 | $0 |
| Total Non-Current Liabilities | $3M | $2M | $6M |
| Total Liabilities | $9M | $10M | $10M |
| — Equity — | |||
| Common Stock | $21K | $23K | $29K |
| Retained Earnings | $779K | -$1M | -$8M |
| Accumulated OCI | $8M | -$642K | -$444K |
| Total Stockholders Equity | $9M | $8M | $6M |
| Total Liabilities & Equity | $18M | $18M | $16M |
| — Key Metrics — | |||
| Total Debt | $4M | $4M | $5M |
| Net Debt | $3M | $4M | $5M |
| Total Investments | $0 | -$25K | $0 |